Showing results (131-140 of 254) with videos related to
Sort By:
Pageof 26
BMC Cancer|December 5, 2024
The epidemiological trends and predictions of esophageal squamous cell carcinoma and gastroesophageal junction carcinoma: an Australian population-based studyShalika Bohingamu Mudiyanselage, Dieu Nguyen, Boxiong Tang, et al.Diabetes Care|January 30, 2007
Increasing expenditure on health care incurred by diabetic subjects in a developing country: a study from IndiaAmbady Ramachandran, Shobhana Ramachandran, Chamukuttan Snehalatha, et al.BMC Research Notes|November 25, 2010
Adiponectin levels in people with Latent Autoimmune Diabetes-a case control studySinead Brophy, Helen Davies, Jeffrey W Stephens, et al.The Plant Journal : for Cell and Molecular Biology|March 29, 2023
Cell-type-specific metabolism in plantsDanilo de Menezes Daloso, Eva Gomes Morais, Karen Fernanda Oliveira E Silva, et al.Endoscopy International Open|May 3, 2021
Training methods in optical diagnosis and characterization of colorectal polyps: a systematic review and meta-analysisSamuel C L Smith, Keith Siau, Rosanna Cannatelli, et al.Frontline Gastroenterology|June 19, 2019
Impact of the Joint Advisory Group on Gastrointestinal Endoscopy (JAG) on endoscopy services in the UK and beyondKeith Siau, John T Green, Neil D Hawkes, et al.The Annals of Pharmacotherapy|December 29, 2021
Development of MDS-Based Predication Model for COPD Severity in Nursing Home ResidentsBarbara Blaylock, Xiaoli Niu, H Edward Davidson, et al.Current Therapeutic Research, Clinical and Experimental|July 26, 2021
Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims DataXiaoli Niu, Syvart Dennen, Carole Dembek, et al.Current Medical Research and Opinion|March 8, 2021
Hospitalization risk among adults with bipolar I disorder treated with lurasidone versus other oral atypical antipsychotics: a retrospective analysis of Medicaid claims dataXiaoli Niu, Phani Veeranki, Syvart Dennen, et al.Journal of Medical Economics|January 19, 2026
Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regressionMazyar Shadman, Walter Bouwmeester, Leyla Mohseninejad, et al.Pageof 26